Proscizen supports investment banks, private equity, venture capital and other financial institutions with regularly updated proprietary datasets, real-time market intelligence and custom research.
Proscizen supports investment banks, private equity, venture capital and other financial institutions with regularly updated proprietary datasets, real-time market intelligence and custom research.
Our insights provide a complete and dynamic view of the global pharma and life sciences landscape, enabling investors to identify opportunities early, assess risks accurately and make confident investment decisions.
We help capital move with clarity.
Intelligence for venture capital firms
Intelligence for private equity firms
Intelligence for angel investor networks
Intelligence for investment banks
Intelligence for investment funds
Intelligence for investment advisors
Intelligence for asset management firms
Intelligence for wealth management firms
Intelligence for insurance companies
Intelligence for trust organizations
We empower Investment Teams, Analysts, Partners and Decision Makers with data-driven intelligence and tailored research support.
Bespoke research to support deal sourcing, due diligence and investment thesis development.
Target market identification, segmentation and in-depth company analysis.
Data-backed market sizing to evaluate growth potential and investment attractiveness.
In-depth coverage and analysis of current and upcoming pharma and life sciences milestones, including clinical, commercial, regulatory, licensing, deals, funding, manufacturing, conference and corporate events.
Pharma & MedTech Intelligence
Detailed vendor intelligence to support partner selection and evaluation.
Discover how Proscizen can help your organization make smarter, faster, and more confident decisions.